Related Experiment Video

Updated: Jun 3, 2026

Site-Specific Lysine Lactylation via Genetic Code Expansion in E. coli and Mammalian Cells
05:58

Site-Specific Lysine Lactylation via Genetic Code Expansion in E. coli and Mammalian Cells

Published on: February 24, 2026

Glutamate receptors in laryngeal cancer cells

Andrzej Stepulak1, Hella Luksch, Ortrud Uckermann

  • 1Department of Biochemistry and Molecular Biology, Medical University, ul Chodźki 1, 20-093 Lublin, Poland. andrzej.stepulak@gmail.com

Anticancer Research
|March 8, 2011
PubMed
Abstract

Insights

Glutamate receptors are present in laryngeal cancer cells and blocking them inhibits tumor growth. This suggests targeting glutamate signaling could be a new therapy for advanced laryngeal squamous cell carcinoma.

Area of Science:

  • Molecular Oncology
  • Cancer Cell Biology
  • Neurobiology of Cancer

Background:

  • Chemotherapy for advanced laryngeal squamous cell carcinoma yields unsatisfactory outcomes.
  • Emerging evidence highlights glutamate's role as a tumor signaling mediator.
  • Novel therapeutic strategies targeting specific metabolic pathways are required.

Purpose of the Study:

  • To investigate the presence and role of glutamate receptor subunits in laryngeal cancer.
  • To evaluate the effect of glutamate receptor antagonists on laryngeal cancer cell proliferation and signaling.

Main Methods:

  • Analysis of glutamate receptor subunit expression in laryngeal cancer cell lines (RK33, RK45) using end-point PCR, real-time PCR, and immunocytochemistry.
  • Assessment of the impact of ionotropic and metabotropic glutamate receptor antagonists on cell proliferation.
  • Evaluation of the effect of glutamate antagonists on extracellular signal-regulated kinases 1/2 (ERK1/2) activity.

Main Results:

  • Glutamate receptor subunits are differentially expressed in the studied laryngeal cancer cell lines.
  • Inhibitors of ionotropic glutamate receptors and a metabotropic glutamate receptor 5 antagonist significantly reduced laryngeal cancer cell proliferation.
  • Glutamate antagonists also modulated the activity of ERK1/2 signaling pathways within the tumor cells.

Conclusions:

  • Signaling pathways involving glutamate receptors play a role in the growth of laryngeal cancer cells.
  • Glutamate receptors represent a potential adjunctive therapeutic target for laryngeal cancer.
  • Further research into targeting glutamate signaling pathways may offer new treatment avenues.

Related Concept Videos

Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Ligand-gated Ion Channels01:19

Ligand-gated Ion Channels

Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...